Close
A list of projects completed from years 2006 - 2021 by principal investigators of CMI.
| CMI Principal Investigator | Position | Project title | Funder | Duration (months) | Year | Grant award |
|---|---|---|---|---|---|---|
| Professor Steve Halligan | Chief Investigator | Prognostic model of ventral hernia recurrence | NIHR RfPB | 24 | 2017 | £145,926 |
| Biomarkers in Crohns disease | NIHR HTA | 18 | 2016 | £248,773 | ||
| NIHR Senior Investigator Award | NIHR | 48 | 2013 | £15,000 PA to investigator £75,000 PA to Trust | ||
| SIGGAR trials of CT colonography | NIHR HTA | 24 | 2012 | £1,858,578 | ||
| Programme Grant: Interventions for more accurate & efficient diagnosis of colorectal cancer | NIHR | 36 | 2008 | £1,529,281 | ||
| Co-applicant | ||||||
| MRC CARP Award | MRC | 36 | 2019 | £254,813 | ||
| Motility in Crohn's Disease | NIHR EME | 36 | 2016 | £900,437 | ||
| METRIC Extension | NIHR HTA | 36 | 2016 | £347,882 | ||
| PERFECTS | St. Mark's Charity | 36 | 2016 | £405,760 | ||
| MROC | NIHR HTA | 48 | 2015 | £1,270,660 | ||
| Arts Award | Wellcome Trust | 36 | 2015 | £39,870 | ||
| Development of TIPS microspheres | Wellcome Trust (WT095752AIA) | 36 | 2013 | £571,930 | ||
| SOCCER study | NIHR HTA 11/136/120 | 24 | 2013 | £203,495 | ||
| METRIC study | NIHR HTA 11/23/01 | 42 | 2012 | £973,839 | ||
| STREAMLINE study | NIHR HTA 10/68/01 | 48 | 2011 | £1,057,175 | ||
| Whole-body MRI in lymphoma | CRUK Biomarkers & Imaging Discovery | 36 | 2011 | £107,659 | ||
| MR-Guided Interventional cancer treatment | Wolfson Foundation | 48 | 2011 | £1,250,00 | ||
| PROSPECT study | NIHR HTA 09/22/49 | 48 | 2010 | £1,365,305 | ||
| CT colonography to colonoscopy registration | Medicsight PLC | 36 | 2010 | £411,000 | ||
| Multimodal Clinical Imaging Resource for Translational Medicine | NIHR | 48 | 2009 | £1,075,000 | ||
| Comprehensive Cancer Imaging | CRUK/EPSRC | 60 | 2008 | £8,000,000 | ||
| CREST trial | CRUK | 60 | 2007 | £425,000 | ||
| Multiscale, multidimensional imaging | MRC | 36 | 2006 | £326,000 | ||
| Professor Stuart Taylor
| Clinical PI | Quantitative Reporting In Crohn’s Disease: Maximising Available MRI Data To Better Direct Patient Treatment, Speed Up Treatment Decisions And Improve Healthcare Outcomes 2020-2023 (academic lead) | Innovate UK | 36 | 2020 | £1,574,006 |
| Real World Evidence Driving Changes in Crohn’s Disease Management Using Quantitative Imaging Analysis | NIHR i41 | 36 | 2020 | £1,063,499 | ||
| Evaluation of Crohn’s disease activity with MRI-adding value though quantitative assessment of intestinal motility | NIHR i41 | 36 | 2017 | £685,467 | ||
| Co-CI | MRI enterography as a predictor of disabling disease in newly diagnosed Crohn's disease | NIHR HTA | 60 | 2016 | £358,183 | |
| Small bowel motility quantified by cine MRI as a predictor of response to biological therapy | NIHR EME | 12 | 2016 | £896,292 | ||
| Co-Applicant | Assessment of gut transit in paediatric constipation without ionizing radiation: Magnetic Resonance Imaging transit minicapsules and methods 2 (MAGIC2) (2019-2022) | NIHR EME | 36 | 2019 | £1,224,841 | |
| Reclassifying constipation using MRI and high-resolution manometry | MRC | 48 | 2016 | £1,225,971 | ||
| Impact of multiparametric MRI on staging and management decisions in women with ovarian cancer Short title: MR in Ovarian Cancer (MROC study) | NIHR | |||||
| Professor Shonit Punwani | Principal Investigator | Novel microstructural (VERDICT and T2 mapping) and metabolic (hyperpolarised 13C-Pyruvate) MR in diagnosis, risk-stratification and treatment response assessment of prostate cancer | CRUK | 60 | 2018 | £2,321,544.59 |
| Developing MRI Magmetic Susceptibility-Based Cancer Oxygenation Mapping (SBCOM) and Investigating its Clinical Potential to Measure Hypoxia in Prostrate Cancer (PCa) | CRUK | 36 | 2018 | £450,000 | ||
| Establishment of BRC Imaging Trial Unit | NIHR | 60 | 2017 | £800,000 | ||
| BBSRC PhD Case Studentship | BBSRC | 48 | 2017 | £100,000 | ||
| Standardisation of Prostate Multi-parametric MRI across UCL Partners | London Cancer | 48 | 2016 | £120,000 | ||
| Imaging Trial Support Funding | UCLH | 48 | 2016 | £400,000 | ||
| Establishment of Hyperpolariser Probe GMP Facility | NIHR | 36 | 2016 | £254,000 | ||
| CombIning advaNces in imagiNg with biOmarkers for improVed diagnosis of Aggressive prosTate cancer (INNOVATE) | Prostate Cancer UK | 48 | 2015 | £534,000 | ||
| Co-I | Learning MRI and histology image mappings for cancer diagnosis and prognosis | EPSRC | 36 | 2018 | £774,000 | |
| The exploitation of a novel image-based risk stratification tool in early prostate cancer - the Re-IMAGINE Consortium | MRC | 60 | 2018 | £6,300,000 | ||
| Development and evaluation of machine learning methods in whole body magnetic resonance imaging with diffusion weighted imaging for staging of patients with cancer. (MAchine Learning In whole Body Oncology, MALIBO) | NIHR EME | 36 | 2015 | £578,000 | ||
| GLINT - developing Gluco-CEST MRI | Horizon 2020 | 60 | 2015 | €6,400,000 | ||
| Professor Margaret Hall-Craggs | Principal Investigator | Imaging Biomarkers of Inflammation in Adolescents: Development and Technical Validation | UCLH Fast Track Grant | 12 | 2016 | £28,500 |
| Quantitative magnetic resonance imaging in juvenile idiopathic arthritis | Radiology Research Trust | 24 | 2015 | £6,000 | ||
| Validation of an objective biomarker of inflammation of the sacroiliac joints in adolescents with juvenile idiopathic arthritis to quantify treatment response | UCLH BRC | 18 | 2015 | £75,395 | ||
| Co-Investigator | MELAMAG Trial: SentiMAG Melanoma. Sentinel Node Biopsy using Magnetic Nanoparticles: A prospective multicentre feasibility non-randomised clinical trial to compare sentinel node biopsy using magnetic nanoparticles vs. standard technique | Technology Strategy Board Grant (Biomedical Research) | 36 | 2013 | £118,000 | |
| SentiMAG Multicentre Trial: Sentinel Node Biopsy using Magnetic Nanoparticles: A prospective multicentre phase II non-randomised clinical trial to compare sentinel node biopsy using magnetic nanoparticles vs. standard technique. | Endomagnetics | 36 | 2013 | £120,000 | ||
| Adolescent hip disease: biomarkers, morphology and PROMS in a longitudinal study | Orthopaedic research UK | 24 | 2013 | £99,817 | ||
| Derivation and internal validation of a clinical decision rule to predict in newborns clinically important hip dysplasia at a minimum of 2 years | NIHR, Research for Patient Benefit Programme | 24 | 2013 | £282,877 | ||
| Professor David Atkinson | Principal Investigator | Towards Reliable Diffusion MRI of Moving Organs | EPSRC | 48 | 2011 | £580,000 |
| Impact PhD Studentship | NIHR/UCL | 48 | 2010 | £48,000 | ||
| Time-resolved whole-heart cardiac imaging using highly parallel magnetic resonance | EPSRC | 36 | 2007 | £360,000 | ||
| HPC Software for Medical Imaging | EPSRC | 24 | 2007 | £468,000 | ||
| Co-Investigator | Exploiting the unique quantitative capabilities offered by simultaneous PET/MRI +Impact Award for 4 PhD studentships. | EPSRC Simems/UCL | 36 | 2013 | £1,300,000 | |
| Intelligent Imaging: Motion, Form and Function Across Scale | EPSRC | 60 | 2010 | £6,000,000 | ||
| Project Grant | BHF | 12 | 2012 | £58,000 | ||
| The UCL Centre for Medical Image Computing | EPSRC Platform Grant | 60 | 2006 | £418,000 |